Donor Government Funding for HIV in Low- and Middle-Income Countries in 2021

Key Findings
  1. UNAIDS, “Global AIDS Update Report”, July 2022.

    ← Return to text

  2. UNAIDS, “Global AIDS Update Report”, July 2022.

    ← Return to text

  3. In 2021, some donor governments provided COVID-specific emergency contributions to the Global Fund and UNITAID in addition to their contributions for core activities. Specifically, Canada, France, Germany, Italy, Japan, and Norway provided COVID-specific funding to UNITAID, while Canada, Germany, Luxembourg, the Netherlands, Norway, Switzerland, and the U.S. provided COVID-specific funding to the Global Fund. For the purposes of this report, these COVID-specific amounts have been excluded as they cannot be attributed to a specific area, such as HIV.

    ← Return to text

  4. Donor government contributions to the Global Fund and UNITAID have been adjusted for an HIV-share to account for the fact that these multilateral organizations address other diseases and areas (see Methodology).

    ← Return to text

  5. In 2021, the U.S. Congress appropriated an additional $3.5 billion in funding (beyond its regular contribution supporting HIV, TB, and malaria activities, which was flat in 2021 compared to the 2020 amount) to support the Global Fund’s efforts to address the COVID-19 pandemic. This funding is not included because it is for COVID-specific activities and cannot be attributed to HIV.

    ← Return to text

  6. U.K. Foreign Commonwealth & Development Office (FCDO), “Statistics on International Development: Provisional UK Aid Spend 2021,” April 2022.

    ← Return to text

  7. In addition to the $5.5 billion disbursed for HIV in 2021 (provided through regular appropriations for bilateral programs as well as the HIV-adjusted share of contributions to the Global Fund and UNAIDS), the U.S. disbursed an additional $4.3 million for bilateral HIV activities from emergency supplemental funding that was provided in response to the COVID-19 pandemic through the “American Rescue Plan Act of 2021” (see KFF analysis of “Global Funding Across U.S. COVID-19 Supplemental Funding Bills”).

    ← Return to text

  8. UNAIDS, “Global AIDS Update Report”, July 2022.

    ← Return to text

  9. OECD, “COVID-19 assistance to developing countries lifts foreign aid in 2021”, April 2022.

    ← Return to text

  10. United Nations Secretary-General, “Deputy Secretary-General’s statement on cuts to Official Development Assistance (ODA)”, May 2022.

    ← Return to text

  11. Global Fund, “Seventh Replenishment Investment Case: Fight for What Counts”, 2022.

    ← Return to text

Report
  1. Donor government disbursements are a subset of overall international assistance for HIV in low-and-middle-income countries, which also includes funding provided by other multilateral institutions, UN agencies, and foundations.

    ← Return to text

  2. UNAIDS, “Global AIDS Update Report”, July 2022.

    ← Return to text

  3. UNAIDS, “Global AIDS Update Report”, July 2022.

    ← Return to text

  4. UNAIDS estimates that US$21.4 billion was available for HIV from all sources (domestic resources, donor governments, multilaterals, and philanthropic organizations) in 2021, expressed in 2019 USD. For purposes of this analysis, this estimate was converted to 2021 USD, or $22.6 billion. In addition, while the amounts presented in this analysis include donor contributions to multilateral organizations, the UNAIDS estimate of total available resources for HIV includes the actual disbursements made by multilateral organizations in 2021 rather than the donor government contributions to these entities.

    ← Return to text

  5. The donor share of total available resources includes bilateral disbursements as well as an adjusted share of Global Fund and UNITAID disbursements (the donor government share of contributions to each of the multilaterals in 2021 is applied to the disbursements from these multilaterals for the same year).

    ← Return to text

  6. The UNAIDS resource needs estimate is expressed in 2019 USD.

    ← Return to text

  7. In addition to the $5.5 billion disbursed for HIV in 2021 (provided through regular appropriations for bilateral programs as well as the HIV-adjusted share of contributions to the Global Fund and UNAIDS), the U.S. disbursed an additional $4.3 million for bilateral HIV activities from emergency supplemental funding that was provided in response to the COVID-19 pandemic through the “American Rescue Plan Act of 2021” (see KFF analysis of “Global Funding Across U.S. COVID-19 Supplemental Funding Bills”).

    ← Return to text

  8. Personal communication with PEPFAR, July 2022.

    ← Return to text

  9. UNAIDS, “World AIDS Day Report, 2021”,

    ← Return to text

  10. Global Fund, “Results Report 2021”, April 2022.

    ← Return to text

  11. WHO, “Third round of the global pulse survey on continuity of essential health services during the COVID-19 pandemic”, February 2022.

    ← Return to text

  12. IMF, “World Economic Outlook: War Sets Back the Global Recovery”, April 2022.

    ← Return to text

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.